Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt

Hideaki Shigematsu, Yoshitaka Hirooka, Kenichi Eshima, Miwako Shihara, Tatsuya Tagawa, Akira Takeshita

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Recent studies have suggested that the central nervous system is responsible for activation of sympathetic nerve activity (SNA) and the renin-angiotensin system in heart failure (HF). The aim of this study was to determine whether activation of the renin-angiotensin system within the nucleus of the solitary tract (NTS) plays a role in enhanced SNA in HF. High-output HF was induced by an aortocaval (A-V) shunt with some modifications in the rat. These rats exhibited a left ventricular dilatation and hemodynamic signs of high-output HF. Urinary catecholamine excretion and maximal renal SNA (RSNA) were greater in the A-V shunted rats than in the control rats. Microinjection of an angiotensin II type 1-receptor antagonist, CV11974, into the NTS was performed. The arterial pressure and RSNA were reduced by CV11974 to a greater degree in the A-V shunted rats than in the control rats. The expression of angiotensin-converting enzyme mRNA in the medulla was greater in the A-V shunted rats than in the control rats. These results suggest that activation of the renin-angiotensin system within the NTS contributes to an enhanced SNA in this model.

Original languageEnglish
Pages (from-to)R1665-R1673
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume280
Issue number6 49-6
DOIs
Publication statusPublished - 2001

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt'. Together they form a unique fingerprint.

Cite this